Close Menu

NEW YORK – Genetron Health, a Chinese cancer molecular profiling and sequencing technology company, said Thursday that it has received approval from the China National Medical Products Administration for a next-generation sequencing system and a kit for an eight-gene lung cancer panel.

The Genetron S2000 is a high-throughput, automated sequencer that can run two types of flow cells, with data output of 55 Gb to 1,440 Gb per run.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.